RESTON, Va., Aug. 26, 2020 /PRNewswire/ -- Appian (NASDAQ:
APPN) today announced survey results exploring how automation
is being used by global leaders in the Life Sciences and
Pharmaceutical industry, revealing that the majority of respondents
are engaged in digital modernization projects.
The "Digital Transformation & the Life Sciences Industry"
survey, sponsored by Appian and conducted by Pharma
Intelligence (Informa), shows that digital modernization is a
priority through key initiatives focusing on process and
operational efficiency. Despite that, automation is currently only
used in 40% of respondents' organizations, although
75% expected to look at automation technologies in the
future.
When asked about specific solutions, the majority (82%)
of those who know about low-code see the benefits of using it to
simplify DevOps for their organization, showing some awareness of
the power low-code automation can have in streamlining processes
and responding to regulatory changes quickly.
On objectives for digital transformation initiatives:
- The majority (84%) of respondents reported current,
active digital modernization projects
- Nearly three-quarters (74%) wanted to use digital
technologies to improve the overall process
- Nearly 70% wanted to use digital technologies to
improve operational efficiency
The two biggest barriers to achieving transformation success are
system complexity (47%) and lack of understanding with the
business or in IT departments (38%). Concern over systems
complexity was a common theme across the survey. The biggest
challenge facing respondents (55%) is "managing complexity",
yet more than half (51%) also felt that customers expect
enhanced automation efficiency, suggesting possible conflict
between priorities using traditional automation systems.
"The results show that organizational leaders in Life Sciences
are increasingly turning to digital transformation - more
specifically, automation," said Evjatar Cohen, Vice President,
Global Life Sciences and Healthcare at Appian. "Collected during
the pandemic, the data suggests that Life Sciences organizations
are facing mounting pressure to free up their skilled workforces
from repetitive tasks and serve patients more efficiently."
To learn more about how low-code automation unlocks efficiency
while reducing complexity to help Life Sciences organizations stay
competitive, read the full "Digital Transformation & the Life
Sciences Industry" survey report.
Methodology
The survey, conducted by Pharma
Intelligence (Informa), gathered responses between April and
July 2020. Respondents came from 196
organizations in the pharmaceutical and life sciences industry with
at least 500 employees, mainly representing organizations
headquartered in the US (44%) and western Europe (38%). The majority of respondents
(78%) held Life Sciences or Pharma roles, with 46% in Director
level positions or higher.
About Appian
Appian provides a low-code development
platform that accelerates the creation of high-impact business
applications. Many of the world's largest organizations use Appian
applications to improve customer experience, achieve operational
excellence, and simplify global risk management and compliance. For
more information, visit www.appian.com.
View original
content:http://www.prnewswire.com/news-releases/survey-84-of-global-life-sciences-leaders-involved-in-digital-modernization-projects-301118218.html
SOURCE Appian